Project Details
Description
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy of Zilucoplan in Subjects with Generalized Myasthenia Gravis
Status | Finished |
---|---|
Effective start/end date | 8/1/19 → 7/31/23 |
Funding
- RA PHARMACEUTICALS, INC